America
Indian drug maker recalls two medicines from US
Bengaluru, June 29
India's pharma major Dr
Reddy's Laboratories Ltd has voluntarily recalled from the US market two
medicines including one used to treat seizures like epilepsy on the
advice of the regulator, an official statement said.
According to
a notification by the US Food and Drug Administration, the firm has
started recalling divalproex sodium tablets, as it has failed
dissolution tests, and amlodipine besylate and atorvastatin calcium
tablets as they are close to expiry time.
The first is used to treat certain types of seizures, while the other two are used to treat high blood pressure and chest pain.
The tablets were made at the company's facility at Bachupally in Hyderabad.

1 hour ago
Celebrating Asian Heritage Month: Bharatanatyam Finds a Place on the Canadian Cultural Stage.

1 hour ago
ALSAC announces Ike Anand as President and Chief Executive Officer, ushering in a new era of innovation and growth

5 hours ago
Ramaswamy targets 'radical' Mamdani, 'invites' NYC people to move Ohio

5 hours ago
'Fueling Putin's war machine': US Senators say penalise India, China, Brazil with 500% tarriff to deter trade with Russia

5 hours ago
Trump's Ultimatum: Russia must make peace with Ukraine in 50 days or face 100% tariff

7 hours ago
Nimisha Priya case: Last-minute negotiations bring big relief to Kerala nurse in Yemen, execution deferred

7 hours ago
Punjab Assembly pays tributes to Fauja Singh

8 hours ago
Makers of Sai Pallavi's 'Gargi' celebrate as film completes three years of its release

8 hours ago
Tillotama Shome to star in Shweta Tripathi’s maiden production 'Mujhe Jaan Na Kaho Meri Jaan'

8 hours ago
Jessica Alba focused on herself, kids and not interested in a relationship right now

8 hours ago
'Heer Express' trailer promises a complete family drama with a tadka of emotions

8 hours ago
Randeep Hooda on 25 years ‘Operation Khukri’: Proud moment for all us Indians

8 hours ago
Viineet Kumar Siingh, Rajshri Deshpande-starrer ‘Rangeen’ to stream from July 25